Related Experiment Videos
Natural history of parainfluenza virus infection in childhood
Insights
Parainfluenza virus (PV) infections are common in infants, with reinfections occurring frequently. Repeated PV exposures are crucial for developing immunity against severe illness in early life.
Area of Science:
- Pediatrics
- Virology
- Immunology
Background:
- Parainfluenza viruses (PV) are significant respiratory pathogens in infants and young children.
- Understanding the natural history of PV infection is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the natural history of parainfluenza virus infection in early life.
- To assess the incidence of primary and reinfections with PV serotypes.
- To evaluate the impact of PV infection on lower respiratory tract illness (LRTI) and the development of immunity.
Main Methods:
- Prospective follow-up of 130 infants and children from birth.
- Utilized rapid diagnostic, tissue culture, and serologic techniques for PV detection.
- Assessed secretory IgA responses using immunofluorescent techniques.
Main Results:
- 92% of infants experienced primary PV infection by 30 months of age.
- 49% had reinfections with PV strains (heterotypic or homotypic).
- Primary PV infection offered brief immunity to LRTI only upon homotypic reinfection; no protection against heterotypic strains.
- Secretory IgA responses were transient after primary/heterotypic infections but enhanced after homotypic reinfections.
Conclusions:
- Repeated exposures to PV are essential for maintaining immunity to severe illness in early life.
- Homotypic reinfection significantly boosts secretory antibody production, indicating a role in long-term immunity.
- PV infection dynamics highlight the need for further research into vaccine development and management of respiratory infections in children.
Abstract:
In order to determine the natural history of parainfluenza virus infection in early life, we followed prospectively 130 infants and children from birth or a few months of age for evidence of infection with PV. Using rapid diagnostic techniques, standard tissue culture infectivity, and serologic techniques we were able to document primary PV infection in 92% of these infants, and repeated infection with heterotypic or homotypic PV strains in 49% by 30 months of age. Increasing patient age had no significant effect in reducing the incidence of lower respiratory tract illness as a result of PV infection. Infection with one PV serotype provided no protection against LRTI at the time of subsequent infection with a heterotypic PV strain. In contrast, primary PV infection provided a brief period of immunity to LRTI upon homotypic reinfection. Secretory IgA responses to PV were determined by immunofluorescent techniques. Antibody response to PV strains causing primary infection and heterotypic repeated infection were transient and of low magnitude. Homotypic reinfection resulted in significantly enhanced production of secretory antibody to PV. At least in early life, repeated exposures to PV appear to be essential for maintaining immunity to severe forms of illness caused by PV infection.